BHBo Hu

Bo Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Hu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Zhiguang Liu

    Clinical Trial Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    5 shared publications
  • Xinyue Lang

    Clinical Trial Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    4 shared publications
  • Biyan Wang

    Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China

    3 shared publications
  • Lap Ah Tse

    Division of Occupational and Environmental Health, Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong, China

    3 shared publications
  • Minghai Yan

    Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China

    3 shared publications
  • Salim Yusuf

    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada

    3 shared publications

Latest Publications

  • Open Access

    Association of vascular aging and insulin resistance with cardiovascular outcomes in China: PURE cohort study

    by Qiujing Cai, Biyan Wang, Minghai Yan, Zhiguang Liu, Xinyue Lang, Emma A van Reekum, Philip Joseph, Sumathy Msc Rangarajan, Lap Ah Tse, Salim Yusuf, et al.

    Background: Although vascular aging and insulin resistance (IR) are recognized contributors to cardiovascular disease (CVD) pathophysiology, their independent and joint associations with CVD outcomes have not been fully clarified in large population-based cohorts. Evidence regarding their complementary rather than mediating roles remains limited. Methods: We used data from the Prospective Urban Rural Epidemiology (PURE) China study, a large prospective cohort comprising 47 931 individuals from 12 provinces across China. Vascular aging was assessed using estimated pulse wave velocity and categorized into supernormal (SVA), healthy (HVA), and early vascular aging (EVA) based on cohort percentiles. IR was evaluated using the triglyceride–glucose (TyG) index. The primary outcome was major CVD events (myocardial infarction, stroke, and heart failure). Cox frailty models with center-level random effects were used to estimate adjusted hazard ratios (aHRs). Results: A total of 40 513 participants with complete information were included in the current study. Over a median follow-up of 11.9 years (interquartile ranges 9.5–12.5), 3615 major CVD events, 829 CVD deaths, and 2344 all-cause deaths occurred. Compared with HVA, EVA was associated with substantially higher risks of major CVD events [aHR = 2.17, 95% confidence interval (CI): 1.99–2.35], CVD mortality (aHR = 4.07, 95% CI: 3.47–4.76), and all-cause mortality (aHR = 2.93, 95% CI: 2.65–3.23), while SVA showed consistently lower risks. Furthermore, higher TyG index levels were independently associated with major CVD event risk in a dose-response manner. Exploratory analyses revealed no significant mediation by the TyG index or interaction between vascular aging and TyG levels. Joint analysis revealed that individuals with both EVA and high TyG had the greatest major CVD risk (aHR = 2.20, 95% CI: 1.75–2.77). Conclusions: EVA and IR were independently associated with higher CVD risk, highlighting the need for integrated vascular-metabolic risk assessment in clinical practice, although further validation is warranted.

  • Open Access

    BMI-stratified cutoff values for spinal sarcopenia in Chinese adults based on CT measures: a multicentre study

    by Wenkai Wu, Fangfang Duan, Zhiguang Liu, Guihe Yang, Chuqi Li, Renxian Wang, Xiaoguang Cheng, Bo Hu, Ling Wang, Yajun Liu

    Decreased size and mass of paraspinal muscles are associated with lower vertebral bone mineral density, more postoperative complications, increased mortality, and spinal sagittal imbalance. However, it is difficult to determine muscle loss in older adults with overweight and obesity. This study aimed to investigate the effects of body mass index (BMI) and central obesity on paraspinal muscle aging and to determine cutoff values for low paraspinal muscle mass/quality in Chinese community populations. In this nationwide cross-sectional study, abdominal CT scans and basic information were collected and analyzed from 4,305 community-dwelling adults from twelve representative cities in China between 2013 and 2017. Psoas and posterior paraspinal muscle index (PMI and PSMI) and density (PMD and PSMD) at the L3 level were measured using OsiriX software. Correlation analysis, multiple linear regression, and one-way ANOVA were performed for statistical analysis. Commonly used cutoff value calculations were applied to define low muscle index and density (Mean–2SD, 5th percentile in young people, and 20th percentile in older people) in the general population and individuals with different BMIs. Correlation analysis showed that the paraspinal muscle index and density were primarily correlated with sex, BMI, and age. Multiple linear regression analysis indicated that the paraspinal muscle index (PSMI and PMI) was primarily influenced by sex (β=–0.391 and − 0.599, p < 0.001) and BMI (β = 0.442 and 0.371, p < 0.001), followed by age and waist circumference. In contrast, muscle density (PSMD and PMD) was mainly associated with sex (β=–0.405 and − 0.317, p < 0.001) and age (β=–0.409 and − 0.429, p < 0.001), with a slight influence from WC and BMI. Considering the significant effect of BMI on muscle mass, we calculated BMI-stratified cutoffs for PSMI (as 12.3/10.6, 15.0/11.7, and 15.2/11.9 cm2/m2 in normal, overweight, and obese men/women using M-2SD), PMI (as 3.8/2.9, 5.0/3.4, and 4.9/3.9 cm2/m2 in normal, overweight and obese men/women using M-2SD), and unstratified cutoffs for PSMD (as 36.3 and 31.1 HU in men and women) and PMD (as 40.1 and 36.9 HU in men and women). This study found that sex and BMI were key determinants of paraspinal muscle mass, with BMI influencing paraspinal muscle number more than age. In contrast, muscle density was primarily influenced by sex and age. This study provided BMI-stratified and non-stratified cutoff values for low paraspinal muscle index and density, which aided in the identification of spinal sarcopenia in individuals with different BMIs.


  • Open Access

    Association of sitting time with cardiovascular events among manual and non-manual workers: a prospective cohort study (PURE-China)

    by Lei Lan, Xinyue Lang, Martin McKee, Lap Ah Tse, Sumathy Rangarajan, Deren Qiang, Zhiguang Liu, Biyan Wang, Zhengrong Liu, Minghai Yan, et al.

    Prolonged sitting time is associated with an increased risk of cardiovascular disease (CVD) in the general population. However, it is unclear how these risks differ across occupational groups. This study aimed to investigate the association between sitting time and CVD in manual and non-manual workers among Chinese adults. This population-based cohort study recruited 47,931 participants aged 35 to 70 years from 115 communities across 12 provinces in China between 2005 and 2009. Daily sitting time was measured using the International Physical Activity Questionnaire (IPAQ). The main outcome was a major CVD event (defined as cardiovascular death, myocardial infarction, stroke, or heart failure). Information on each participant’s occupation was collected using standardized questionnaires and categorized into manual and non-manual occupations according to the Italian National Institute of Statistics 2001 (ISTAT-2001) occupational classification standard. Cox frailty models were used to examine the associations. Of 43,256 in the final sample (excluding those with CVD at baseline and missing data), 25,252 (58.4%) were women, and the mean (± SD, Standard Deviation) age was 50.6 ± 9.5 years. During a median follow-up of 11.9 (IQR, Interquartile Range: 9.5–12.6) years, 3,408 major CVD events (899 myocardial infarctions, 2,400 strokes, 240 incident heart failure, and 764 cardiovascular deaths) were documented. Compared with the reference group (< 4 h per day of sitting), the risk of major CVD events was positively associated with increasing sitting time among manual workers (HR, 1.20; 95% CI, 1.05–1.37 for 6–8 h per day; HR, 1.43; 95% CI, 1.12–1.82 for ≥ 8 h per day), while the risk among non-manual workers was greater for those reporting daily sitting times of more than 8 h (HR, 1.86; 95% CI, 1.18–2.95). Similar trends were observed when CVD mortality and incidence were analysed separately. Longer daily sitting time was associated with an increased risk of major CVD in both manual and non-manual occupational groups, and the risk was especially high among non-manual workers. Our findings highlight the importance of including measures to reduce sedentary behaviour within a comprehensive strategy to reduce the burden of cardiovascular disease in China.


  • Open Access

    Association between Preserved Ratio Impaired Spirometry with mortality and long-term cardiovascular outcomes in Chinese adults

    by Mengya Li, Yang Li, Mengxin Chen, Duong Mylinh, Qiujing Cai, Biyan Wang, Sumathy Rangarajan, Kai You, Jiying Li, Salim Yusuf, et al.

    Background To examine the prevalence and characteristics of PRISm among Chinese individuals, as well as its association with future mortality and cardiovascular (CVD) outcomes. Methods This was a substudy of the Prospective Urban Rural Epidemiology (PURE) study, which recruited 40,279 individuals aged 35-70 years from 115 urban and rural communities in 12 provinces across China between 2005 and 2009. At baseline, participants were categorized into subgroups based on PRISm, airflow obstruction (AO), and normal spirometry. Follow-up was conducted every three years to obtain information on major cardiovascular events and mortality. Cox frailty proportional hazard regression was used to estimate the hazard ratios (HR) and 95% confidence interval (95%CI). Results The baseline prevalence rates of PRISm, AO and normal spirometry were 29.3%, 8.5%, and 62.2% respectively. Over a median follow-up period of 11.9 years, 2,214 deaths, with 773 attributed to CVD, and 3,507 major CVD events were observed. After adjusting for potential confounders, individuals with PRISm, comparing to those with normal spirometry, exhibited significantly elevated risks of all-cause mortality (HR 1.42, 95%CI [1.29, 1.58]), CVD mortality (HR 1.35, 95%CI [1.14, 1.60]), major CVD events (HR 1.16, 95%CI [1.07, 1.25]), myocardial infarction (HR 1.34, 95%CI [1.15,1.56]), and heart failure (HR 2.02, 95%CI [1.46, 2.79]). Conclusions PRISm, a frequently observed result in spirometry among the general Chinese population, exhibits a substantial association with long-term all-cause mortality, CVD mortality, major CVD events. Further investigation is warranted to comprehensively compared the underlying pathophysiologic connection between PRISm and CVD as well as mortality. What is already known on this topic PRISm is considered a transient state with higher transition rates to both normal and obstructive spirometry, often indicating progression to COPD, which is associated with increased respiratory symptoms, diminished quality of life, and a higher risk of cardiovascular events and all-cause mortality. Given the limited understanding of PRISm, there are several studies on the association between PRISm and health outcomes have been carried out in different populations since the concept of PRISm was introduced in 2014. Longitudinal studies based on population cohorts such as COPDGene, UK Biobank, Rotterdam, and NHLBI have shown that PRISm is associated with an increased risk of all-cause mortality and adverse cardiovascular outcomes, with similar results found in a study based on a Japanese population. Lung function differs substantially between races and regions. Most of the existing PRISm-related studies are based on populations in developed countries such as Europe and the United States, and the conclusions of these studies should not be directly generalized to East Asian populations, including China. Currently, there is only two studies based on a Japanese and Korean aimed at exploring the relationship between PRISm and all-cause mortality and adverse cardiovascular outcomes, but the sample size of these study is relatively small, and the statistical power of the conclusions is relatively limited. What this study adds This is the first longitudinal study examining the association of PRISm with the risk for all-cause mortality and adverse cardiovascular outcomes in a general Chinese population. The results showed that the prevalence of PRISm in the general Chinese population is 29.3%, which is significantly higher than previous studies. Compared to individuals with normal spirometry, the population with baseline PRISm had a significantly increased risk of all-cause mortality, CVD mortality, myocardial infarction (MI), and heart failure (HF), and showed a trend towards higher risk than those with baseline airflow obstruction (AO, although no statistically significant difference was observed). How this study might affect research, practice or policy Our findings support that the early prevention, diagnosis, and intervention of PRISm may offer an important strategy to alleviating the high CVD burden in China.

  • Open Access

    Association of preserved ratio impaired spirometry with mortality and cardiovascular diseases: a systematic review and meta-analysis

    by Mengya Li, Mengxin Chen, Yang Li, Zhiguang Liu, Xiaocong Li, Xinyue Lang, Bo Hu, Wei Li

    Background: Preserved ratio impaired spirometry (PRISm) is a type of abnormal lung function. PRISm and mortality have been explored in several studies, but a comprehensive evaluation of the associations is limited. The current study aims to conduct a systematic review and meta-analysis in order to investigate the mortality and cardiovascular diseases in patients with PRISm. Methods: PubMed, Embase, and Web of Science databases, as well as gray literature sources, were searched for relevant studies published up to 7 September 2023 without language restrictions. This review included all published observational cohort studies that investigated the association of PRISm with mortality in the general population, as well as subgroup analyses in smokers and pre-bronchodilation spirometry studies. The outcomes of interest were all-cause mortality, cardiovascular mortality, and respiratory-related mortality. The Newcastle–Ottawa scale assessed study quality. Sensitivity and subgroup analyses explored heterogeneity and robustness. Publication bias was assessed with Egger’s and Begg’s tests. Results: Overall, eight studies were included in this meta-analysis. The pooled HR was 1.60 (95% CI, 1.48–1.74) for all-cause mortality, 1.68 (95% CI, 1.46–1.94) for CVD mortality, and 3.09 (95% CI, 1.42–6.71) for respiratory-related mortality in PRISm group compared to normal group. In the subgroup analysis, participants with PRISm had a higher effect (HR, 2.11; 95% CI, 1.74–2.54) on all-cause mortality among smokers relative to participants with normal spirometry. Furthermore, the association between PRISm and mortality risk was consistent across several sensitivity analyses. Conclusions: People with PRISm were associated with an increased risk of all-cause mortality, CVD mortality, and respiratory-related mortality as compared to those with normal lung function in the general population. Systematic review registration: PROSPERO CRD42023426872.


  • Open Access

    Achievement of Guideline-Recommended Targets for Secondary Prevention of Cardiovascular Disease in 38 Low-Income and Middle-Income Countries

    by Zhiguang Liu, Minghai Yan, Lap Ah Tse, Yingxuan Zhu, Xinyue Lang, Xin Liu, Yang Lin, Bo Hu

    Background: This study aimed to estimate the prevalence of achieving the secondary prevention targets recommended in the World Health Organization (WHO) guidelines for cardiovascular disease (CVD) in 38 low-income and middle-income countries (LMICs). Methods: We pooled nationally representative cross-sectional surveys from 38 LMICs between 2013 and 2020. Treatment, metabolic and lifestyle targets were assessed for individuals with a self-reported history of CVD according to WHO’s recommendations. Associations between the prevalence of guideline adherence and sociodemographic characteristics were assessed using multivariate Poisson regression models. Results: The pooled sample included 126 106 participants, of whom 9821 (6.8% [95% CI 6.4–7.2]) reported a history of CVD. Overall, the prevalence of achieving treatment targets in patients with CVD was 22.7% (95% CI, 21.0-24.5%) for antihypertensive drugs, 19.6% (17.9-21.4%) for aspirin, and 13.6% (12.0-15.44%) for statins. The prevalence of achieving metabolic targets was 54.9% (52.5-57.3%) for BMI, 39.9% (37.7-42.2%) for blood pressure, 46.1% (43.6-48.6%) for total cholesterol, and 84.9% (83.1-86.5%) for fasting blood glucose. The prevalence of achieving lifestyle targets was 83.2% (81.5-84.7%) for not smoking, 83.1% (81.2-84.9%) for not drinking, 65.5% (63.1-67.7%) for sufficient physical activity and 16.2% (14.5-18.0%) for healthy diet. Only 6.1% (5.1-7.4%) achieved three treatment targets, 16.0% (14.3-17.9%) achieved four metabolic targets, and 6.9% (5.8-8.0%) achieved four lifestyle targets. Upper-middle income countries were better than low-income countries at achieving the treatment, non-drinking and dietary targets. Being younger and female were associated with poorer achievement of metabolic targets. Conclusion: In LMICs, achieving the targets recommended in the guideline for treatment, metabolism and healthy lifestyles for patients with CVD is notably low. This highlights an urgent need for effective, systematic secondary prevention strategies to improve CVD management.


  • Open Access

    Interaction of Depression and Unhealthy Diets on the Risk of Cardiovascular Diseases and All-Cause Mortality in the Chinese Population: A PURE Cohort Substudy

    by Xinyue Lang, Zhiguang Liu, Shofiqul Islam, Guoliang Han, Sumathy Rangarajan, Lap Ah Tse, Maha Mushtaha, Junying Wang, Lihua Hu, Deren Qiang, et al.

    This study aimed to identify the interaction of depression and diets on cardiovascular diseases (CVD) incident and death in China and key subpopulations. We included 40,925 participants from the Prospective Urban Rural Epidemiology (PURE)-China cohort which recruited participants aged 35–70 years from 45 urban and 70 rural communities. Depression was measured by the adapted Short-Form (CIDI-SF). The unhealthy diet was considered when the score of Alternative Healthy Eating Index was below the lowest tertile. The primary outcome was a composite outcome of incident CVD and all-cause mortality. Cox frailty models were used to examine the associations. During a median follow-up of 11.9 years (IQR: 9.6–12.6 years), depression significantly increased the risk of the composite outcome (HR = 2.00; 95% CI, 1.16–3.27), major CVD (HR = 1.82; 95% CI, 1.48–2.23), and all-cause mortality (HR = 2.21; 95% CI, 1.51–3.24) for the unhealthy diet group, but not for the healthy diet group. The interaction between depression and diet for the composite outcome was statistically significant (RERI = 1.19; 95% CI, 0.66–1.72; AP = 0.42, 95% CI, 0.27–0.61; SI = 3.30, 95% CI, 1.42–7.66; multiplicative-scale = 1.74 95% CI, 1.27–2.39), even in the subgroup and sensitivity analyses. In addition, the intake of vegetable and polyunsaturated fatty acids contributed most to the interaction of diets and depression. Depressive participants should focus on healthy diets, especially vegetables and polyunsaturated fatty acids, to avoid premature death and CVD.